Galmed Pharmaceuticals annual free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Galmed Pharmaceuticals Free Cash Flow (FCF) History (GLMD)
Galmed Pharmaceuticals reported −$18.5M in free cash flow for fiscal 2022, an increase of $14.4M from the previous fiscal year.
View full Galmed Pharmaceuticals company overviewGalmed Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$18.5M | $14.4M | — | — |
| 2021 | 2021-12-31 | −$32.9M | −$6.6M | — | — |
| 2020 | 2020-12-31 | −$26.3M | −$11.4M | — | — |
| 2019 | 2019-12-31 | −$14.9M | −$5.8M | — | — |
| 2018 | 2018-12-31 | −$9.1M | $3.0M | — | −447.15% |
| 2017 | 2017-12-31 | −$12.1M | $67,000 | — | −1113.27% |
| 2016 | 2016-12-31 | −$12.1M | −$3.5M | — | −2600.86% |
| 2015 | 2015-12-31 | −$8.6M | $1.4M | — | — |
| 2014 | 2014-12-31 | −$10.0M | −$7.5M | — | — |
| 2013 | 2013-12-31 | −$2.5M | $574,000 | — | — |
| 2012 | 2012-12-31 | −$3.1M | — | — | — |
Galmed Pharmaceuticals quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Galmed Pharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$12.1M to −$18.5M, a net decrease of $6.4M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Galmed Pharmaceuticals filings at SEC.gov ↗